MedPath

Proclara Biosciences, Inc.

Proclara Biosciences, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2006-01-01
Employees
11
Market Cap
-
Website
http://www.proclarabio.com

Multiple Ascending Dose Study in Healthy Subjects

Phase 1
Terminated
Conditions
Amyloidosis
Interventions
First Posted Date
2019-03-18
Last Posted Date
2019-08-19
Lead Sponsor
Proclara Biosciences, Inc.
Target Recruit Count
8
Registration Number
NCT03879278
Locations
🇳🇱

PRA Health Sciences, Groningen, Netherlands

A Study of NPT189 in Healthy Subjects

Phase 1
Completed
Conditions
Amyloidosis
Interventions
Drug: Placebo
First Posted Date
2018-08-01
Last Posted Date
2019-08-15
Lead Sponsor
Proclara Biosciences, Inc.
Target Recruit Count
48
Registration Number
NCT03610035
Locations
🇳🇱

PRA Health Sciences, Groningen, Netherlands

Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease

Phase 1
Completed
Conditions
Alzheimer Disease
Interventions
Drug: Placebo
First Posted Date
2017-01-02
Last Posted Date
2019-08-15
Lead Sponsor
Proclara Biosciences, Inc.
Target Recruit Count
83
Registration Number
NCT03008161
Locations
🇺🇸

Neurology Center of North Orange County, Fullerton, California, United States

🇺🇸

NeuroStudies LLC, Decatur, Georgia, United States

🇺🇸

Princeton Medical Institute, Princeton, New Jersey, United States

and more 20 locations
© Copyright 2025. All Rights Reserved by MedPath